日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Benefit-risk balance of S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)

S-1 与 UFT 作为 II/III 期直肠癌辅助化疗的获益风险平衡 (JFMC35-C1: ACTS-RC)

Chiem, Jean-Christophe; Alharazin, Hatem; Saad, Everardo D; Oba, Koji; Muto, Masaru; Yamagishi, Hisakazu; Sakamoto, Junichi; Yoshikawa, Takaki; Buyse, Marc

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

局部晚期直肠癌的新辅助治疗

Audisio, Alessandro; Gallio, Chiara; Velenik, Vaneja; Meillat, Hélène; Ruiz-Garcia, Erika; Riesco, Maria Carmen; Alecha, Javier Suárez; Rasschaert, Gertjan; Carvalho, Carlos; Randrian, Violaine; Kirac, Iva; Hernando, Jorge; Artaç, Mehmet; O'Connor, Juan Manuel; Waldhorn, Ithai; Braam, Pètra M; Shamseddine, Ali; Moretto, Roberto; De la Pinta, Carolina; De Felice, Francesca; Dulskas, Audrius; Páez López-Bravo, David; Vanden Bulcke, Alexander; Bock, Felix; Deleporte, Amélie; Van Den Eynde, Marc; Geboes, Karen P; Loi, Mauro; Messina, Marco; Houlzé-Laroye, Constance; Puccini, Alberto; Pastorino, Alessandro; Papamichael, Demetris; Fiore, Michele; Sur, Daniel; Eid, Michal; Antoun, Claire; Salati, Massimiliano; Garajovà, Ingrid; Jakubauskas, Matas; Tomášek, Jirí; Sousa Pinto, Cidália Maria; Schwingel, Jerome; Morano, Federica; Adams, Richard A; Dermine, Alexandre; Chau, Amélie; Javed, Muhammad Ahsan; Ghidini, Michele; Fiorica, Francesco; Montenegro, Paola; Petrillo, Angelica; Spolverato, Gaya; Mulet Margalef, Núria; Diaz, Marie; Baratelli, Chiara; Puleo, Francesco; Karampeazis, Athanasios; Sert, Fatma; Gilliaux, Quentin; De Stefano, Alfonso; Liberale, Gabriel; Moretti, Luigi; Martinive, Philippe; Deltuvaite Thomas, Vaiva; Staggs, Vincent; Saad, Everardo D; Van Laethem, Jean-Luc; Sclafani, Francesco

Generalized Pairwise Comparisons to Support Shared Decision-Making in the CODA Trial

在CODA试验中,采用广义成对比较法支持共同决策

Salvaggio, Samuel; Monsell, Sarah E; Heagerty, Patrick J; De Backer, Mickael; Barré, Emilie; Chiem, Jean-Christophe; Saad, Everardo D; Buyse, Marc; Flum, David R

Trial Design for Cancer Immunotherapy: A Methodological Toolkit

癌症免疫疗法试验设计:方法学工具包

Saad, Everardo D; Coart, Elisabeth; Deltuvaite-Thomas, Vaiva; Garcia-Barrado, Leandro; Burzykowski, Tomasz; Buyse, Marc

Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology

转移性癌症临床试验终点:利用个体参与者数据指导未来试验方法

Goldberg, Richard M; Adams, Richard; Buyse, Marc; Eng, Cathy; Grothey, Axel; André, Thierry; Sobrero, Alberto F; Lichtman, Stuart M; Benson, Al B; Punt, Cornelis J A; Maughan, Tim; Burzykowski, Tomasz; Sommeijer, Dirkje; Saad, Everardo D; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C; Zalcberg, John; Tabernero, Josep; Van Cutsem, Eric; Matheson, Alastair; de Gramont, Aimery

Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy

代孕超越预后:试验级代孕的重要性

Buyse, Marc; Saad, Everardo D; Burzykowski, Tomasz; Regan, Meredith M; Sweeney, Christopher S

The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration

反对在癌症临床试验中审查无进展生存期——以疫情封锁为例

Jamoul, Corinne; Collette, Laurence; Coart, Elisabeth; D'Hollander, Koenraad; Burzykowski, Tomasz; Saad, Everardo D; Buyse, Marc

Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core

巴西对欧洲癌症研究与治疗组织 (EORTC) 生活质量组 (QLG) 计算机自适应测试 (CAT) 核心的验证

Marta, Gustavo Nader; de Souza, Tomás Y T; Silva, Alice R N de Souza E; Pereira, Ana Paula A; Ferreira Neto, David R; Asso, Rie N; Degrande, Fabiana A M; Nader-Marta, Guilherme; da Silva, Maurício F; Gadia, Rafael; Hanna, Samir A; Holzner, Bernhard; Saad, Everardo D; Petersen, Morten Aagaard

Central statistical monitoring of investigator-led clinical trials in oncology

肿瘤学领域研究者主导的临床试验的集中统计监测

Buyse, Marc; Trotta, Laura; Saad, Everardo D; Sakamoto, Junichi

Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis

在接受曲妥珠单抗辅助治疗长达 1 年的试验中,无病生存期作为 HER2 阳性早期乳腺癌患者总生存期的替代指标:一项系统评价和荟萃分析

Saad, Everardo D; Squifflet, Pierre; Burzykowski, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P; Slamon, Dennis; Wolmark, Norman; Buyse, Marc